Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
82 CHF +0.61% Intraday chart for SKAN Group AG +5.13% +1.49%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : SKAN Group AG, 2023 Earnings Call, Mar 26, 2024
Switzerland's SKAN Group Logs Improved FY23 Profit, Revenue MT
SKAN Group AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : SKAN Group AG, H1 2023 Earnings Call, Aug 22, 2023
Switzerland's Skan Group Swings to H1 Profit; Net Sales Grow MT
SKAN Group AG Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Berenberg Lifts Price Target on Skan Group, Maintains Buy Recommendation MT
SKAN Group Chairman to Abstain Amid Swiss Attorney General Probe MT
SKAN Faces Probe from Swiss Attorney General Over BV Holding Share Transactions MT
SKAN Group AG Approves Dividend CI
Skan Boosts Stake in Belgian Unit Aseptic Technologies MT
Certain Shares of SKAN Group AG are subject to a Lock-Up Agreement Ending on 28-APR-2023. CI
Skan Appoints Chief Services Officer MT
Skan Posts Higher FY22 Attributable Profit MT
SKAN Group AG Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Certain Shares of SKAN Group AG are subject to a Lock-Up Agreement Ending on 28-OCT-2022. CI
SKAN Group AG(SWX:SKAN) added to S&P Global BMI Index CI
SKAN Confirms FY22 Guidance on Record Order Backlog, Posts H1 Loss MT
SKAN Group AG Confirms Earnings Guidance for the Full Year 2022 CI
SKAN Group AG Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Switzerland's SKAN Boosts Stake in Belgian Unit Aseptic Technologies MT
SKAN Group AG Approves Dividend, Payable on May 10, 2022 CI
SKAN Group AG Provides Revenue Guidance for the Full Year of 2022 CI
SKAN Group AG Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Lloyd Fonds AG acquired 50% of stake in SKAN Group AG. CI
Chart SKAN Group AG
More charts
SKAN Group AG, former BV Holding AG, is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
82 CHF
Average target price
91.33 CHF
Spread / Average Target
+11.38%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SKAN Stock
  4. News SKAN Group AG
  5. Switzerland's SKAN Boosts Stake in Belgian Unit Aseptic Technologies